Prot #ML29366: An Open-Label, Single-Arm, Phase II Study Of Pertuzumab With High-Dose Trastuzumab For The Treatment Of Central Nervous System Progression Post-Radiotherapy In Patients With Her2-Positive Metastatic Breast Cancer (Patricia)

Project: Research project

Project Details

StatusFinished
Effective start/end date11/6/15 → 12/31/21

Funding

  • Quintiles, Inc. (Prot #ML29366 // Prot #ML29366)
  • Genentech, Inc (Prot #ML29366 // Prot #ML29366)